« Return to News | CROs/Service Providers

Medpace to undergo equity recapitilization

Tuesday, May 24, 2011 10:51 AM

US-based CRO Medpace will undergo an “equity recapitalization” with affiliates of CCMP Capital Advisors, under which CCMP will end up with an 80% stake in the company while the remaining 20% share will belong to the current Medpace management team, according to Pharma Times.

No financial details were released.

The existing Medpace management will remain in place, as will August Troendle as president and chief executive officer. Medpace will also continue to operate out of Cincinnati, Ohio once the recapitalization is completed.

Medpace’s relationship with CCMP will allow the CRO to “add global operational depth” and to further its reputation as “a company well-known for therapeutic and operational excellence” in conducting phase I-IV clinical studies.

“The transaction will provide resources to make the strategic long-term investments that are needed to advance our leadership position, grow the core business, and expand our global reach,” commented Troendle. 

Medpace has more than 1,000 employees and clinical trial experience in over 40 countries.

As well as phase II-IV development services, the CRO provides phase I/ IIA clinical services through Medpace Clinical Pharmacology; central laboratory and therapeutically specialized testing through Medpace Reference Laboratories; bioanalytical services through Medpace Bioanalytical Laboratories; centralized imaging core laboratory management and reading through Imagepace; and medical device development through Medpace Medical Device.

.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.